Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-12

Clinical Trial Update: Safety and Tolerability of Zelquistinel in Normal Human Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and tolerability of Zelquistinel in healthy volunteers has completed. The trial lists Major Depressive Disorder as the condi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zelquistinel (Zelquistinel)

Snippet

Sponsor: Syndeio Biosciences, Inc | Conditions: Major Depressive Disorder | Phase 1 | Status: COMPLETED